Published in Science Translational Medicine · View the paper (DOI)
Researchers found that PBT2 disrupts metals in polymyxin-resistant bacteria, resensitizing them to treatment and boosting survival rates in mice with sepsis. The compound may offer a solution to the growing threat of antibiotic resistance, which poses a grave danger to patients with bacterial infections.
Coverage from 2 institutions